ATLAS / Macro Radar / Reporting / PHIO

Phio Pharmaceuticals Corp. (PHIO) reporting calendar

Phio Pharmaceuticals Corp. files periodic reports with the SEC as PHIO on Nasdaq. Atlas tracks 57 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
19 Jul 2026 – 9 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
57

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open PHIO market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001437749-26-015604
10-K31 Dec 20255 Mar 202664 days0001437749-26-007078
10-Q30 Sep 202513 Nov 202544 days0001437749-25-034857
10-Q30 Jun 202514 Aug 202545 days0001683168-25-006174
10-Q31 Mar 202515 May 202545 days0001683168-25-003719
10-K31 Dec 202431 Mar 202590 days0001683168-25-002134
10-Q30 Sep 202414 Nov 202445 days0001683168-24-008120
10-Q30 Jun 202414 Aug 202445 days0001683168-24-005706
10-Q31 Mar 20249 May 202439 days0001683168-24-003175
10-K31 Dec 20231 Apr 202492 days0001683168-24-002021
10-Q30 Sep 20239 Nov 202340 days0001683168-23-007809
10-Q30 Jun 202310 Aug 202341 days0001683168-23-005514
10-Q31 Mar 202311 May 202341 days0001683168-23-003213
10-K31 Dec 202222 Mar 202381 days0001683168-23-001678
10-Q30 Sep 202210 Nov 202241 days0001683168-22-007528
10-Q30 Jun 202211 Aug 202242 days0001683168-22-005565
10-Q31 Mar 202212 May 202242 days0001683168-22-003516
10-K31 Dec 202122 Mar 202281 days0001683168-22-001833
10-Q30 Sep 202110 Nov 202141 days0001683168-21-005420
10-Q30 Jun 202112 Aug 202143 days0001683168-21-003476
10-Q31 Mar 202113 May 202143 days0001683168-21-001971
10-K31 Dec 202025 Mar 202184 days0001683168-21-001062
10-Q30 Sep 202010 Nov 202041 days0001683168-20-003809
10-Q30 Jun 202012 Aug 202043 days0001683168-20-002649
10-Q31 Mar 202012 May 202042 days0001683168-20-001519
10-K31 Dec 201926 Mar 202086 days0001683168-20-000969
10-Q30 Sep 201912 Nov 201943 days0001683168-19-003526
10-Q30 Jun 201912 Aug 201943 days0001683168-19-002547
10-Q31 Mar 201914 May 201944 days0001683168-19-001519
10-K31 Dec 201827 Mar 201986 days0001683168-19-000795
10-Q30 Sep 201814 Nov 201845 days0001683168-18-003390
10-Q30 Jun 201814 Aug 201845 days0001683168-18-002282
10-Q31 Mar 201810 May 201840 days0001193125-18-158327
10-K31 Dec 201726 Mar 201885 days0001193125-18-096053
10-Q30 Sep 20178 Nov 201739 days0001193125-17-336446
10-Q30 Jun 201710 Aug 201741 days0001193125-17-253552
10-Q31 Mar 201711 May 201741 days0001193125-17-166563
10-K31 Dec 201630 Mar 201789 days0001193125-17-102730
10-Q30 Sep 201610 Nov 201641 days0001193125-16-765096
10-Q30 Jun 201611 Aug 201642 days0001193125-16-678578

Source: SEC EDGAR company submissions for CIK 0001533040. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.